BUCKSCO.Today on MSN11d
A Planned GSK Expansion Pushes Company Beyond Montgomery County
GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...
JD Supra22d
GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
On October 15, 2024, GSK filed two complaints against Moderna in the District Court for the District of Delaware, asserting that Moderna willfully infringes GSK’s mRNA patent portfolio. In Civil ...
Business Insider7d
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...
Nature3y
How GlaxoSmithKline is advancing efficient drug development in haematologic malignancies
At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...
Reuters on MSN1mon
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
(Reuters) - GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights ...
GlaxoSmithKline Pharma Q2 results: Net profit rises 16% to Rs 252 cr
GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.
devdiscourse17d
GlaxoSmithKline's Strong Quarterly Profit Growth and Special Dividend Declaration
GlaxoSmithKline Pharmaceuticals reported a notable 16% rise in consolidated net profit for the September quarter, reaching Rs 252 crore. This growth was driven by robust sales and brand performance.
BBC5y
GlaxoSmithKline and Pfizer merge healthcare arms
Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...
GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y
Other Operating Income------Total Income From Operations: 1,010.77: 814.65: 956.99: EXPENDITURE ...
Reuters17d
India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand
Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...
Wall Street Journal4y
GlaxoSmithKline Pharmaceuticals Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...